Download | < Back |
15 May 2017 | |
With reference to the captioned subject, this is to inform the exchange that the Company has received U.S. Food & Drug Administration (FDA) approval for Fenofibric Acid Delayed-Release Capsules. Please find enclosed herewith our press release. We request you to kindly take the same on record. | |
View all announcements for ALEMBIC PHARMACEUTICALS LTD. | Source: BSE India |